Gene therapy using genome‐edited iPS cells for targeting malignant glioma

Glioblastoma is characterized by diffuse infiltration into the normal brain. Invasive glioma stem cells (GSCs) are an underlying cause of treatment failure. Despite the use of multimodal therapies, the prognosis remains dismal. New therapeutic approach targeting invasive GSCs is required. Here, we s...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamura, Ryota, Miyoshi, Hiroyuki, Imaizumi, Kent, Yo, Masahiro, Kase, Yoshitaka, Sato, Tsukika, Sato, Mizuto, Morimoto, Yukina, Sampetrean, Oltea, Kohyama, Jun, Shinozaki, Munehisa, Miyawaki, Atsushi, Yoshida, Kazunari, Saya, Hideyuki, Okano, Hideyuki, Toda, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Special Issue Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487333/
https://www.ncbi.nlm.nih.gov/pubmed/37693056
http://dx.doi.org/10.1002/btm2.10406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487333/
https://www.ncbi.nlm.nih.gov/pubmed/37693056
http://dx.doi.org/10.1002/btm2.10406

Ejemplares similares